Cargando…
The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation
AIM/HYPOTHESIS: Efficiency in controlling chronic diseases, especially in the primary care setting, is associated with reduced rates of hospitalizations. Poorly controlled diabetes is associated with severe diabetic decompensation, such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic s...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Primary Care Diabetes Europe. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266494/ https://www.ncbi.nlm.nih.gov/pubmed/37353465 http://dx.doi.org/10.1016/j.pcd.2023.06.001 |
_version_ | 1785058751417417728 |
---|---|
author | Pina, Henrique Martins, João Dinis Guerra, Sílvia Aragüés, José Maria Valadas, Cristina |
author_facet | Pina, Henrique Martins, João Dinis Guerra, Sílvia Aragüés, José Maria Valadas, Cristina |
author_sort | Pina, Henrique |
collection | PubMed |
description | AIM/HYPOTHESIS: Efficiency in controlling chronic diseases, especially in the primary care setting, is associated with reduced rates of hospitalizations. Poorly controlled diabetes is associated with severe diabetic decompensation, such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS). It is hypothesized that, in addition to the SARS-CoV2 pandemic, there was a parallel increase in decompensation of previously controlled chronic diseases, such as diabetes. In this work, the impact of the SARS-CoV2 pandemic on hospitalizations for severe diabetic decompensation in a Portuguese hospital was assessed. METHODS: A retrospective study by hospital clinical file consultation was performed and a cohort of 177 patients admitted to a Portuguese hospital with a diagnosis of DKA or hyperosmolar hyperglycemic state HHS, excluding SARS-CoV2 infected patients, between 2019 and 2020 was analysed. RESULTS: In the population not infected by SARS-CoV2, statistically significant differences were found in the relative number of hospitalizations (5.59 vs 3.79 hospitalizations for DKA/HHS per 1000 patients not infected with SARS-CoV2, p = 0.0093) and lethality due to DKA/HHS (0941 vs 0337 deaths from DKA/HHS per 1000 patients not infected with SARS-CoV2, p = 0.0251). This increase in hospitalizations and lethality was accompanied by a statistically significant increase in newly type 2 diabetes diagnosis in DKA/HHS hospital admissions (p = 0.0156) and by a statistically significant increase in average age of patients (56.3 ± 22.4 vs 69.1 ± 17.6, p < 0.001). DISCUSSION AND CONCLUSIONS: These results show the empirical perspective that the consequences of the pandemic also had a considerable impact on the control of chronic diseases such as diabetes, with a higher percentage of hospitalizations due to severe decompensation, especially in the elderly population. |
format | Online Article Text |
id | pubmed-10266494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Primary Care Diabetes Europe. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102664942023-06-15 The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation Pina, Henrique Martins, João Dinis Guerra, Sílvia Aragüés, José Maria Valadas, Cristina Prim Care Diabetes Brief Report AIM/HYPOTHESIS: Efficiency in controlling chronic diseases, especially in the primary care setting, is associated with reduced rates of hospitalizations. Poorly controlled diabetes is associated with severe diabetic decompensation, such as diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic state (HHS). It is hypothesized that, in addition to the SARS-CoV2 pandemic, there was a parallel increase in decompensation of previously controlled chronic diseases, such as diabetes. In this work, the impact of the SARS-CoV2 pandemic on hospitalizations for severe diabetic decompensation in a Portuguese hospital was assessed. METHODS: A retrospective study by hospital clinical file consultation was performed and a cohort of 177 patients admitted to a Portuguese hospital with a diagnosis of DKA or hyperosmolar hyperglycemic state HHS, excluding SARS-CoV2 infected patients, between 2019 and 2020 was analysed. RESULTS: In the population not infected by SARS-CoV2, statistically significant differences were found in the relative number of hospitalizations (5.59 vs 3.79 hospitalizations for DKA/HHS per 1000 patients not infected with SARS-CoV2, p = 0.0093) and lethality due to DKA/HHS (0941 vs 0337 deaths from DKA/HHS per 1000 patients not infected with SARS-CoV2, p = 0.0251). This increase in hospitalizations and lethality was accompanied by a statistically significant increase in newly type 2 diabetes diagnosis in DKA/HHS hospital admissions (p = 0.0156) and by a statistically significant increase in average age of patients (56.3 ± 22.4 vs 69.1 ± 17.6, p < 0.001). DISCUSSION AND CONCLUSIONS: These results show the empirical perspective that the consequences of the pandemic also had a considerable impact on the control of chronic diseases such as diabetes, with a higher percentage of hospitalizations due to severe decompensation, especially in the elderly population. Primary Care Diabetes Europe. Published by Elsevier Ltd. 2023-06-14 /pmc/articles/PMC10266494/ /pubmed/37353465 http://dx.doi.org/10.1016/j.pcd.2023.06.001 Text en © 2023 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Brief Report Pina, Henrique Martins, João Dinis Guerra, Sílvia Aragüés, José Maria Valadas, Cristina The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation |
title | The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation |
title_full | The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation |
title_fullStr | The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation |
title_full_unstemmed | The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation |
title_short | The silent diabetic decompensation epidemic during the SARS-CoV2 pandemic – The role of primary care in early diagnosis and prevention of severe diabetic decompensation |
title_sort | silent diabetic decompensation epidemic during the sars-cov2 pandemic – the role of primary care in early diagnosis and prevention of severe diabetic decompensation |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266494/ https://www.ncbi.nlm.nih.gov/pubmed/37353465 http://dx.doi.org/10.1016/j.pcd.2023.06.001 |
work_keys_str_mv | AT pinahenrique thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT martinsjoaodinis thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT guerrasilvia thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT araguesjosemaria thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT valadascristina thesilentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT pinahenrique silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT martinsjoaodinis silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT guerrasilvia silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT araguesjosemaria silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation AT valadascristina silentdiabeticdecompensationepidemicduringthesarscov2pandemictheroleofprimarycareinearlydiagnosisandpreventionofseverediabeticdecompensation |